{
    "id": "34f44991-fc66-a383-e063-6294a90a24cf",
    "indications": "Sodium polystyrene sulfonate for suspension is indicated for the treatment of hyperkalemia.\n                  \n                     Limitation of Use:\n\n \n                  Sodium polystyrene sulfonate for suspension should not be used as an emergency treatment for life-threatening hyperkalemia because of its delayed onset of action [see\n \n  \n                        Clinical Pharmacology (12.2)\n                     ]",
    "contraindications": "Oral : The average total daily adult dose of sodium polystyrene sulfonate is 15 g to 60 g, administered as a 15-g dose (four level teaspoons), one to four times daily ( 2.1 ). Rectal : The average adult dose is 30 g to 50 g every six hours ( 2.1 ).",
    "warningsAndPrecautions": "Sodium polystyrene sulfonate for suspension is available as a golden brown, finely ground powder.\n                  NDC: 72162-1230-02: in jars of 1 pound (454 g).\n                  NDC: 72162-1230-07: in bottles of 15 g,\n                  Store at 25°C (77°F); excursions permitted to 15°-30°C (59°-86°F) [see USP Controlled Room Temperature].\n                  Repackaged/Relabeled by:\n  \nBryant Ranch Prepack, Inc.\n  \nBurbank, CA 91504",
    "adverseReactions": "Sodium polystyrene sulfonate is contraindicated in patients with the following conditions:\n                  \n                     Hypersensitivity to polystyrene sulfonate resins\n                     Obstructive bowel disease\n                     Neonates with reduced gut motility",
    "ingredients": [
        {
            "name": "SODIUM POLYSTYRENE SULFONATE",
            "code": "1699G8679Z"
        }
    ],
    "organization": "Bryant Ranch Prepack",
    "name": "SODIUM POLYSTYRENE SULFONATE",
    "effectiveTime": "20250512"
}